Pfizer Inc (PFE)

$25.45 +0.42 (1.68%)
Market Cap 142.54B
Revenue (ttm) 62.58B
Net Income (ttm) 7.77B
EPS (ttm) N/A
PE Ratio 8.14
Forward PE 8.43
Profit Margin 12.42%
Debt to Equity Ratio 0.71
Volume 40,247,940
Avg Vol 42,255,047
Day's Range N/A - N/A
Shares Out 5.70B
Stochastic %K 56%
Beta 0.35
Analysts Sell
Price Target $28.70

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
StockPikAlliance
StockPikAlliance Aug. 4 at 7:11 PM
$PFE Q2 revenue reached $15B and adjusted EPS hit $0.77, beating estimates by 13%. Eliquis sales surged 21% to $2.43B, while Padcev and other oncology products continued gaining momentum. Pfizer raised 2026 revenue guidance to $60.5B to $62.5B and now targets $9.7B in total cost savings by 2029. Add a $0.43 quarterly dividend and major upside from its oncology and obesity pipelines. New all time highs are coming much sooner than investors expect! 🐂🔥🚀
0 · Reply
Micheal_Pothead
Micheal_Pothead Aug. 4 at 6:46 PM
$PFE The sad thing is.. Up 1.5% on an earnings beat is unheard of here
0 · Reply
nimii
nimii Aug. 4 at 6:45 PM
$PFE 26 tomorrow
0 · Reply
VeryBerryBusy
VeryBerryBusy Aug. 4 at 6:28 PM
$PFE what a turd
0 · Reply
smartfellar
smartfellar Aug. 4 at 5:44 PM
$PFE yawn
0 · Reply
LetsgoRandy
LetsgoRandy Aug. 4 at 5:36 PM
$NVO Novo cannot win against Mounjaro on "injected semaglutide vs. tirzepatide weight-loss percentages", said the smartest AI. $LLY $PFE $SPY
0 · Reply
NorthOfSouth
NorthOfSouth Aug. 4 at 5:21 PM
$PFE
0 · Reply
EarningsInsider
EarningsInsider Aug. 4 at 5:15 PM
https://www.marketbeat.com/earnings/reports/2026-8-4-pfizer-inc-stock/ $PFE Pfizer Earnings Transcript
0 · Reply
Duker1976
Duker1976 Aug. 4 at 5:06 PM
$PFE here's hoping they go hard after Sellas Life Sciences, $SLS
0 · Reply
TheUnmaker
TheUnmaker Aug. 4 at 5:05 PM
$TNXP Looks bottomed to me. $PFE $JNJ $PG $SLS
2 · Reply
Latest News on PFE
Pfizer Earnings Call Transcript: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 5 hours ago

Pfizer Earnings Call Transcript: Q2 2026

Pfizer Earnings release: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 5 hours ago

Pfizer Earnings release: Q2 2026

Pfizer Slides: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 5 hours ago

Pfizer Slides: Q2 2026

Pfizer Quarterly report: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 5 hours ago

Pfizer Quarterly report: Q2 2026

Pfizer Stock (PFE) Falls on 2026 Sales Outlook as Cancer Drugs Fuel Q2 Beat

2026-08-04T11:39:45.000Z - 7 hours ago

Pfizer Stock (PFE) Falls on 2026 Sales Outlook as Cancer Drugs Fuel Q2 Beat

Pfizer Post Loss on Higher Revenue

Aug 4, 2026, 7:24 AM EDT - 7 hours ago

Pfizer Post Loss on Higher Revenue

Pfizer tops quarterly estimates, hikes low end of revenue guidance on strength of non-Covid products

Aug 4, 2026, 7:13 AM EDT - 8 hours ago

Pfizer tops quarterly estimates, hikes low end of revenue guidance on strength of non-Covid products

Why Pfizer Stock and This Covid Vaccine Partner Are Falling on Earnings

Aug 4, 2026, 7:12 AM EDT - 8 hours ago

Why Pfizer Stock and This Covid Vaccine Partner Are Falling on Earnings

BNTX

Pfizer reports Q2 adjusted EPS 77c, consensus 68c

2026-08-04T10:52:17.000Z - 8 hours ago

Pfizer reports Q2 adjusted EPS 77c, consensus 68c

Pfizer beats quarterly profit estimates on strong demand for blood thinner Eliquis

Aug 4, 2026, 6:52 AM EDT - 8 hours ago

Pfizer beats quarterly profit estimates on strong demand for blood thinner Eliquis

Pfizer backs FY26 adjusted EPS view $2.80-$3.00, consensus $2.95

2026-08-04T10:51:36.000Z - 8 hours ago

Pfizer backs FY26 adjusted EPS view $2.80-$3.00, consensus $2.95

Pfizer announces expansion of productivity enhancement Initiatives

2026-08-04T10:50:31.000Z - 8 hours ago

Pfizer announces expansion of productivity enhancement Initiatives

Pfizer Reports Second-Quarter Results And Raises Midpoint of 2026 Revenue Guidance

Aug 4, 2026, 6:45 AM EDT - 8 hours ago

Pfizer Reports Second-Quarter Results And Raises Midpoint of 2026 Revenue Guidance

5 Things to Know Before the Stock Market Opens on Monday

Aug 3, 2026, 8:10 AM EDT - 1 day ago

5 Things to Know Before the Stock Market Opens on Monday

AMD AZN BMY CAT CVS DASH DIS

Pfizer's oral drug restores skin pigmentation in late-stage vitiligo trials

Jul 30, 2026, 7:48 AM EDT - 5 days ago

Pfizer's oral drug restores skin pigmentation in late-stage vitiligo trials

Pfizer says LITFULO studies meet co-primary endpoints

2026-07-30T11:03:18.000Z - 5 days ago

Pfizer says LITFULO studies meet co-primary endpoints

Pfizer Announces Positive Topline Phase 3 Results for LITFULO in Patients with Nonsegmental Vitiligo

Jul 30, 2026, 6:45 AM EDT - 5 days ago

Pfizer Announces Positive Topline Phase 3 Results for LITFULO in Patients with Nonsegmental Vitiligo

EC authorizes Pfizer, BioNTech XFG-adapted COVID-19 vaccine in EU

2026-07-29T20:42:19.000Z - 5 days ago

EC authorizes Pfizer, BioNTech XFG-adapted COVID-19 vaccine in EU

BNTX

European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union

Jul 29, 2026, 4:30 PM EDT - 5 days ago

European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union

BNTX

Pfizer's prostate cancer drug combination gets US FDA priority review

Jul 22, 2026, 4:48 PM EDT - 12 days ago

Pfizer's prostate cancer drug combination gets US FDA priority review

FDA grants priority review for Pfizer’s Talzena plus Xtandi

2026-07-22T20:40:37.000Z - 12 days ago

FDA grants priority review for Pfizer’s Talzena plus Xtandi

FDA Grants Priority Review for Pfizer's TALZENNA Plus XTANDI for the Treatment of Metastatic Prostate Cancer

Jul 22, 2026, 4:30 PM EDT - 12 days ago

FDA Grants Priority Review for Pfizer's TALZENNA Plus XTANDI for the Treatment of Metastatic Prostate Cancer

Trump says generic drugs to face no US tariffs for 2 years before rates of 100% and 200% later

Jul 21, 2026, 7:10 PM EDT - 13 days ago

Trump says generic drugs to face no US tariffs for 2 years before rates of 100% and 200% later

LLY

Pfizer suspends sales of Premarin vaginal cream in India, citing supply challenges

Jul 16, 2026, 1:39 PM EDT - 19 days ago

Pfizer suspends sales of Premarin vaginal cream in India, citing supply challenges

U.S. FDA Approves PADCEV® plus Keytruda® as Neoadjuvant and Adjuvant Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

Jul 10, 2026, 11:23 AM EDT - 25 days ago

U.S. FDA Approves PADCEV® plus Keytruda® as Neoadjuvant and Adjuvant Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

Options Corner: PFE Downgrade, Stock Slides Near 52-Week Low

Jul 6, 2026, 10:00 AM EDT - 4 weeks ago

Options Corner: PFE Downgrade, Stock Slides Near 52-Week Low

Value stocks beat growth when inflation is high. Here are 13 stocks top newsletters are betting on now.

Jun 29, 2026, 4:43 PM EDT - 5 weeks ago

Value stocks beat growth when inflation is high. Here are 13 stocks top newsletters are betting on now.

ABT ADM APD BAC CMCSA CVS DIS

Pfizer, Innovent GLP-1 drugs pass China insurance preliminary review

Jun 29, 2026, 1:20 AM EDT - 5 weeks ago

Pfizer, Innovent GLP-1 drugs pass China insurance preliminary review

Pfizer Declares Third-Quarter 2026 Dividend

Jun 24, 2026, 3:52 PM EDT - 5 weeks ago

Pfizer Declares Third-Quarter 2026 Dividend

FDA Approves Pfizer's IBRANCE Regimen for HR+, HER2+ Metastatic Breast Cancer Frontline Maintenance

Jun 24, 2026, 2:10 PM EDT - 5 weeks ago

FDA Approves Pfizer's IBRANCE Regimen for HR+, HER2+ Metastatic Breast Cancer Frontline Maintenance

Pfizer dismissed from US states' drug price-fixing lawsuit

Jun 24, 2026, 10:51 AM EDT - 5 weeks ago

Pfizer dismissed from US states' drug price-fixing lawsuit

China outpacing Europe in drug innovation and development, Pfizer executive says

Jun 23, 2026, 12:10 PM EDT - 6 weeks ago

China outpacing Europe in drug innovation and development, Pfizer executive says

Pfizer Invites Public to View and Listen to Webcast of August 4 Conference Call with Analysts

Jun 23, 2026, 10:00 AM EDT - 6 weeks ago

Pfizer Invites Public to View and Listen to Webcast of August 4 Conference Call with Analysts

Pfizer's experimental drug misses main goal of lung cancer trial

Jun 22, 2026, 4:43 PM EDT - 6 weeks ago

Pfizer's experimental drug misses main goal of lung cancer trial

Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer

Jun 22, 2026, 4:30 PM EDT - 6 weeks ago

Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer

Wall Street loves growth stocks — but these 10 ‘losers' are primed to win

Jun 22, 2026, 2:32 PM EDT - 6 weeks ago

Wall Street loves growth stocks — but these 10 ‘losers' are primed to win

ACHR AGCO COF DHI DVN EOG TSN

Pfizer CFO Dave Denton to step down, leave company in August

Jun 18, 2026, 6:52 AM EDT - 6 weeks ago

Pfizer CFO Dave Denton to step down, leave company in August

Pfizer Announces Chief Financial Officer Transition

Jun 18, 2026, 6:45 AM EDT - 6 weeks ago

Pfizer Announces Chief Financial Officer Transition

Pfizer CEO warns German investment at risk over drug pricing policies

Jun 10, 2026, 7:56 AM EDT - 7 weeks ago

Pfizer CEO warns German investment at risk over drug pricing policies

Want to Avoid the Whipsawing Tech Stocks? Dollar General and 7 Others to Buy.

Jun 9, 2026, 2:07 PM EDT - 2 months ago

Want to Avoid the Whipsawing Tech Stocks? Dollar General and 7 Others to Buy.

DG ALGN BBY BIIB CVS VZ

Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying

Jun 9, 2026, 9:20 AM EDT - 2 months ago

Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying

AMGN JNJ LLY MRK NVO

The space race is coming for pharma: Why drug development is heading to lower Earth orbit

Jun 9, 2026, 3:20 AM EDT - 2 months ago

The space race is coming for pharma: Why drug development is heading to lower Earth orbit

BMY LLY MRK RDW UTHR XBI

Pfizer Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Jun 8, 2026, 8:00 AM EDT - 2 months ago

Pfizer Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

US FDA approves Pfizer's bleeding disorder drug for children

Jun 8, 2026, 6:49 AM EDT - 2 months ago

US FDA approves Pfizer's bleeding disorder drug for children

U.S. FDA Approves Pfizer's HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need

Jun 8, 2026, 6:45 AM EDT - 2 months ago

U.S. FDA Approves Pfizer's HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need

Pfizer Transcript: Study update

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Transcript: Study update

Pfizer Slides: Study update

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Slides: Study update

Pfizer Press release: Study update

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Press release: Study update

Pfizer's monthly obesity shot has side-effect profile similar to Wegovy in midstage trial

Jun 6, 2026, 9:06 AM EDT - 2 months ago

Pfizer's monthly obesity shot has side-effect profile similar to Wegovy in midstage trial

Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer's GLP-1 RA Berobenatide

Jun 6, 2026, 9:00 AM EDT - 2 months ago

Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer's GLP-1 RA Berobenatide

Chai Discovery Announces License Agreement with Pfizer to Accelerate Drug Discovery with AI

Jun 4, 2026, 10:00 AM EDT - 2 months ago

Chai Discovery Announces License Agreement with Pfizer to Accelerate Drug Discovery with AI

Why Pfizer And Eli Lilly Are Betting On This $1.3 Billion AI Drug Discovery Startup

Jun 4, 2026, 6:40 AM EDT - 2 months ago

Why Pfizer And Eli Lilly Are Betting On This $1.3 Billion AI Drug Discovery Startup

LLY

Pfizer Transcript: Jefferies Global Healthcare Conference 2026

Jun 3, 2026, 2:00 PM EDT - 2 months ago

Pfizer Transcript: Jefferies Global Healthcare Conference 2026

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Jun 1, 2026, 10:00 AM EDT - 2 months ago

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Pfizer's BRAFTOVI Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer

May 31, 2026, 8:00 AM EDT - 2 months ago

Pfizer's BRAFTOVI Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer

TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer

May 30, 2026, 8:00 AM EDT - 2 months ago

TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer

Seven-Year Analysis from Pfizer's LORBRENA CROWN Trial Shows Longest Progression-Free Survival Reported to Date in Advanced Non-Small Cell Lung Cancer

May 29, 2026, 8:00 AM EDT - 2 months ago

Seven-Year Analysis from Pfizer's LORBRENA CROWN Trial Shows Longest Progression-Free Survival Reported to Date in Advanced Non-Small Cell Lung Cancer

Innovent Biologics shares rise 10% after pact with Pfizer of up to $10.5 billion

May 28, 2026, 11:10 PM EDT - 2 months ago

Innovent Biologics shares rise 10% after pact with Pfizer of up to $10.5 billion

China's Innovent Biologics, Pfizer strike up to $10.5 billion cancer drug deal

May 28, 2026, 7:19 PM EDT - 2 months ago

China's Innovent Biologics, Pfizer strike up to $10.5 billion cancer drug deal

Innovent Biologics and Pfizer Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

May 28, 2026, 7:00 PM EDT - 2 months ago

Innovent Biologics and Pfizer Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

Pfizer and Innovent Biologics Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

May 28, 2026, 7:00 PM EDT - 2 months ago

Pfizer and Innovent Biologics Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

May 27, 2026, 10:00 AM EDT - 2 months ago

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

Sarah Cannon Research Institute Announces Strategic Oncology Research Collaboration with Pfizer

May 20, 2026, 9:00 AM EDT - 2 months ago

Sarah Cannon Research Institute Announces Strategic Oncology Research Collaboration with Pfizer

Pfizer's pneumococcal shot shows stronger immune response in mid-stage trial

May 20, 2026, 5:08 AM EDT - 2 months ago

Pfizer's pneumococcal shot shows stronger immune response in mid-stage trial

Pfizer Advances Pivotal Pediatric Pneumococcal Vaccine Program Following Strong Positive Phase 2 Results

May 20, 2026, 5:05 AM EDT - 2 months ago

Pfizer Advances Pivotal Pediatric Pneumococcal Vaccine Program Following Strong Positive Phase 2 Results

StockPikAlliance
StockPikAlliance Aug. 4 at 7:11 PM
$PFE Q2 revenue reached $15B and adjusted EPS hit $0.77, beating estimates by 13%. Eliquis sales surged 21% to $2.43B, while Padcev and other oncology products continued gaining momentum. Pfizer raised 2026 revenue guidance to $60.5B to $62.5B and now targets $9.7B in total cost savings by 2029. Add a $0.43 quarterly dividend and major upside from its oncology and obesity pipelines. New all time highs are coming much sooner than investors expect! 🐂🔥🚀
0 · Reply
Micheal_Pothead
Micheal_Pothead Aug. 4 at 6:46 PM
$PFE The sad thing is.. Up 1.5% on an earnings beat is unheard of here
0 · Reply
nimii
nimii Aug. 4 at 6:45 PM
$PFE 26 tomorrow
0 · Reply
VeryBerryBusy
VeryBerryBusy Aug. 4 at 6:28 PM
$PFE what a turd
0 · Reply
smartfellar
smartfellar Aug. 4 at 5:44 PM
$PFE yawn
0 · Reply
LetsgoRandy
LetsgoRandy Aug. 4 at 5:36 PM
$NVO Novo cannot win against Mounjaro on "injected semaglutide vs. tirzepatide weight-loss percentages", said the smartest AI. $LLY $PFE $SPY
0 · Reply
NorthOfSouth
NorthOfSouth Aug. 4 at 5:21 PM
$PFE
0 · Reply
EarningsInsider
EarningsInsider Aug. 4 at 5:15 PM
https://www.marketbeat.com/earnings/reports/2026-8-4-pfizer-inc-stock/ $PFE Pfizer Earnings Transcript
0 · Reply
Duker1976
Duker1976 Aug. 4 at 5:06 PM
$PFE here's hoping they go hard after Sellas Life Sciences, $SLS
0 · Reply
TheUnmaker
TheUnmaker Aug. 4 at 5:05 PM
$TNXP Looks bottomed to me. $PFE $JNJ $PG $SLS
2 · Reply
jrh34
jrh34 Aug. 4 at 5:03 PM
$PFE a golden cross in a couple weeks launches this above $32/share.
0 · Reply
Micheal_Pothead
Micheal_Pothead Aug. 4 at 4:53 PM
$PFE back to normal
0 · Reply
StockPikAlliance
StockPikAlliance Aug. 4 at 4:52 PM
$PFE Q2 revenue hit $15B. 🔥 New and acquired products grew 18%. Guidance was raised!!! Now add oncology momentum, obesity upside, and major pipeline readouts. The massive rerating is just beginning! 🐂 🚀
0 · Reply
nimii
nimii Aug. 4 at 4:46 PM
$PFE
0 · Reply
thebrockettman
thebrockettman Aug. 4 at 4:34 PM
$PFE Finally positive on YTD chart! 🚀🚀
0 · Reply
CloudCapital
CloudCapital Aug. 4 at 4:30 PM
$PFE Compare the balance sheets. BSEM has negative equity and high debt, RMTG actually has healthy shareholders equity. Huge contrast.
0 · Reply
TheUnmaker
TheUnmaker Aug. 4 at 4:09 PM
$TNXP Juice it over $11.85 / $12.42 / $12.95! $SLS $PFE $GALT $INBS
0 · Reply
GreenHawkz
GreenHawkz Aug. 4 at 4:06 PM
$VKTX and yet $PFE still higher than VKTX today 😂
0 · Reply
PFElinepfrenzy1990
PFElinepfrenzy1990 Aug. 4 at 4:01 PM
$PFE
0 · Reply
msoi
msoi Aug. 4 at 3:49 PM
$PFE a good move for a valuw stock
0 · Reply
chuckieclam
chuckieclam Aug. 4 at 3:27 PM
$VKTX $PFE PFE Drops 2 Metsera Drugs thanks Bavariaron. pfizer is a train wreck and they LOVE that LOSER bourla 😂😂😂
0 · Reply
VeryBerryBusy
VeryBerryBusy Aug. 4 at 3:16 PM
$PFE surprise surprise beats but still barely budges POS
0 · Reply